Primary Job Title General Partner Primary Organization Treo Ventures
Location United States, North America Gender Male
Investor Type
LinkedIn View on LinkedIn
Brad was Head of Johnson & Johnson Development Corporation (JJDC) from 2011 to 2015. JJDC is Johnson & Johnson’s venture investing arm and has investors based in Si-Valley, Boston, Shanghai, London and Tel Aviv. He established JJDC’s west coast office in 1997 and was an investor in medical devices, healthtech, and biotech for JNJ from
1992-2011.
Prior to JJDC, Brad worked in preclinical surgery and product development at Ethicon, JNJ’s wound closure company, in projects to develop lasers, blood compatible polymers, wound healing stimulation, internal and external stapling and suture materials. Prior to joining JJDC he was in JNJ’s Corporate Office of Science and Technology focused on next generation procedures and biomaterials for medical device applications.
Dr. Vale received a PhD in Biomedical Engineering from Iowa State University on the development of blood compatible polymers and a Doctor of Veterinary Medicine from Washington State University.
